Cyathin A4
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-01102 |
| CAS | |
| Molecular Weight | 334.45 |
| Molecular Formula | C20H30O4 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Cyathus helenae, C. africanus. It has weak activity against gram-positive bacteria, negative bacteria, actinomycetes and dermatophytes, and has anti-ischemia effect (improving cerebral ischemia in rat model).
- Specification
- Properties
- Reference Reading
- Price Product List
| IUPAC Name | (3aR,5aR,9R,10aR)-9-hydroxy-8-(hydroxymethyl)-1-(1-hydroxypropan-2-yl)-3a,5a-dimethyl-3,4,5,9,10,10a-hexahydro-2H-cyclohepta[e]inden-6-one |
| Canonical SMILES | CC(CO)C1=C2C3CC(C(=CC(=O)C3(CCC2(CC1)C)C)CO)O |
| InChI | InChI=1S/C20H30O4/c1-12(10-21)14-4-5-19(2)6-7-20(3)15(18(14)19)9-16(23)13(11-22)8-17(20)24/h8,12,15-16,21-23H,4-7,9-11H2,1-3H3/t12?,15-,16-,19-,20-/m1/s1 |
| InChI Key | SBABRWMIXWNDTO-YXDXTEDTSA-N |
| Appearance | Clear Oily Matter |
| Antibiotic Activity Spectrum | Gram-positive bacteria; Gram-negative bacteria; Fungi |
| BBF-01210 | Emericid | Inquiry |
| BBF-02800 | DB-2073 | Inquiry |
| BBF-01737 | Cordycepin | Inquiry |
| BBF-03428 | Tubermycin B | Inquiry |
| BBF-01829 | Deoxynojirimycin | Inquiry |
| BBF-05886 | Notoginsenoside R1 | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
